Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$478K Sell
3,975
-163
-4% -$18.8K 0.04% 163
2025
Q4
$436K Buy
+4,138
New +$388K 0.04% 191
2024
Q4
Sell
-3,035
Closed -$345K 336
2024
Q3
$345K Buy
3,035
+1,256
+71% +$149K 0.03% 169
2024
Q2
$220K Sell
1,779
-923
-34% -$119K 0.02% 217
2024
Q1
$357K Sell
2,702
-1,800
-40% -$222K 0.03% 175
2023
Q4
$491K Buy
4,502
+443
+11% +$46K 0.04% 144
2023
Q3
$418K Sell
4,059
-4,614
-53% -$497K 0.03% 168
2023
Q2
$1M Sell
8,673
-250
-3% -$28.4K 0.07% 135
2023
Q1
$949K Sell
8,923
-8,343
-48% -$901K 0.07% 134
2022
Q4
$1.92M Buy
17,266
+1,289
+8% +$132K 0.18% 99
2022
Q3
$1.38M Sell
15,977
-969
-6% -$86.5K 0.12% 112
2022
Q2
$1.54M Buy
16,946
+628
+4% +$55.7K 0.12% 108
2022
Q1
$1.34M Sell
16,318
-1,044
-6% -$82.3K 0.09% 123
2021
Q4
$1.33M Buy
+17,362
New +$1.38M 0.1% 88

Other funds holding MRK

American Trust's MRK Position: Q1 2026 in Review

American Trust reduced its Merck (MRK) stake by 3.9% in Q1 2026, selling an estimated $18.8K and leaving 3,975 shares worth $478K. The position accounts for 0.04% of the portfolio, ranked #163.

American Trust first reported a position in MRK in Q4 2021 and has held it in 14 quarters since. The position peaked at $1.92M in Q4 2022. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • American Trust held 3,975 shares of Merck worth $478K as of Q1 2026.
  • American Trust sold 163 Merck shares in Q1 2026, an estimated $18.8K.
  • Merck made up 0.04% of American Trust's portfolio in Q1 2026, its #163 holding.
  • American Trust first reported a position in Merck in Q4 2021 and has held it in 14 quarters since.
  • American Trust's Merck position peaked at $1.92M in Q4 2022.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on American Trust's 13F filing for Q1 2026, filed 1 May 2026.